Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions.
about
Side effects of radiographic contrast media: pathogenesis, risk factors, and preventionThe potential use of biomarkers in predicting contrast-induced acute kidney injurySildenafil citrate for prophylaxis of nephropathy in an animal model of contrast-induced acute kidney injuryReducing contrast-induced acute kidney injury using a regional multicenter quality improvement interventionAcute kidney injury following peripheral angiography and endovascular therapy: A systematic review of the literature.Change in hospital-level use of transradial percutaneous coronary intervention and periprocedural outcomes: insights from the national cardiovascular data registryTemporal trends of fluoroscopy time and contrast utilization in coronary chronic total occlusion revascularization: insights from a multicenter United States registry.Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registryAcute kidney injury by radiographic contrast media: pathogenesis and prevention.SCAI expert consensus statement: 2016 best practices in the cardiac catheterization laboratory: (Endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologia intervencionista; Affirmation of value by the Canadian AssoContrast Volume/Raw eGFR Ratio for Predicting Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention for Myocardial Infarction.The association between contrast dose and renal complications post PCI across the continuum of procedural estimated risk.Estimation of GFR in South Asians: a study from the general population in Pakistan.Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trialAcute Kidney Injury Risk Prediction in Patients Undergoing Coronary Angiography in a National Veterans Health Administration Cohort With External ValidationAre intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?Contrast-induced acute kidney injury: how much contrast is safe?Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study.Estimating GFR prior to contrast medium examinations--what the radiologist needs to know!Association of Variation in Contrast Volume With Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention.Contrast-Induced Acute Kidney Injury: An Update.Acute kidney injury among ST elevation myocardial infarction patients treated by primary percutaneous coronary intervention: a multifactorial entity.Prognostic Implications of Acute Renal Impairment among ST Elevation Myocardial Infarction Patients with Preserved Left Ventricular FunctionReducing Acute Kidney Injury Due to Contrast Material: How Nurses Can Improve Patient SafetyContrast Volume-to-Creatinine Clearance Ratio Predicts the Risk of Contrast-Induced Nephropathy After Percutaneous Coronary Intervention in Patients With Reduced Ejection Fraction.Renal Protection Using Remote Ischemic Peri-Conditioning During Inter-Facility Helicopter Transport of Patients With ST-Segment Elevation Myocardial Infarction: A Retrospective Study.Contrast Volume to Cystatin C-Based Glomerular Filtration Ratio Predicts the Risk of Contrast-Induced Nephropathy After Cardiac Catheterization.Contemporary practice patterns related to the risk of acute kidney injury in the catheterization laboratory: Results from a survey of Society of Cardiovascular Angiography and Intervention (SCAI) cardiologists.Accuracy of GFR estimating equations in a large Swedish cohort: implications for radiologists in daily routine and research.Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.Admission Glucose Levels and the Risk of Acute Kidney Injury in Nondiabetic ST Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.Intravenous Hydration and Contrast-Induced Acute Kidney Injury: Too Much of a Good Thing?Dosing of iodinated contrast volume: a new simple algorithm to stratify the risk of contrast-induced nephropathy in patients with acute coronary syndrome.Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit?Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.Renal impairment according to acute kidney injury network criteria among ST elevation myocardial infarction patients undergoing primary percutaneous intervention: a retrospective observational study.Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working Group.Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. JSN, JRS, and JCS Joint Working Group.Contrast Utilization During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry.Acute kidney injury: Intravenous hydration for the prevention of CIAKI.
P2860
Q26853304-169DF7EC-2296-4831-9DFC-E720FCE27D27Q28078393-13178815-839E-4300-B705-0F058A0473BFQ28545221-725FA6A5-7106-42FE-80C7-0C89D2C7416AQ28602648-7D5040B7-0072-4AA5-9A1F-5FCB64A978E3Q30251827-FDDF20EE-D7EE-4ADB-B8E3-D83BC8D85185Q30829141-5903633C-A8F3-40AD-B168-1C6C6A10C973Q33875729-22533535-1B57-4602-B291-B2C75676B39CQ34005294-911D1CF6-78C8-47E6-B78A-BD0E84A86DBCQ34114127-620EF2B3-ABA6-4E77-829E-C86E0E421598Q34524667-F27A5641-4973-4131-8EE7-FDB0669CB4A5Q35081495-44E6091F-09E7-4385-BEA1-2EEDDB4A2BFBQ35119798-90E08542-73FD-4F85-ABFE-2F1E168D38BBQ35597386-3212E48C-2270-4CD2-8457-6235183C4AE0Q36262721-A49376C9-7B3D-44FE-8E91-A1E894719103Q36836473-62FB979D-1162-4CA2-B69C-88ADAC5CBF48Q37981625-29F83F54-50F9-4464-A21D-4C0C56BD2BEEQ38081850-E45BE1F8-DFF5-431D-AB87-F1FB021FE454Q38413665-2197F20F-2804-4E68-AC90-FB7B479E0602Q38504884-2AE79FF9-9576-414B-9CF8-579FB103453EQ38692733-10C0520E-0C82-40B7-A969-41569ED2D613Q38701320-1064DEAA-E447-462F-9B1B-7172718A7649Q38727914-046EAD87-788A-4689-85FE-3C164DF81E3EQ38969689-4A5A434E-4B69-47ED-AD4A-A81A556A537CQ38985809-1BB09FE8-27E0-4427-BCF6-295E80ED330CQ39185292-71A07286-7145-41BA-BE11-76C7C58C2053Q39215652-D1090B89-D60E-47CA-9D01-C7A2A99184F6Q39628664-0B5D78A8-8E06-43AC-BF42-E2846730D04CQ39674875-C6DBE5D0-C432-4388-B91F-BAE7FC7E85CEQ39776605-B6B384DF-D1E0-4A86-AC9A-96588A6C25DFQ40785392-F84504EC-899B-4C26-A3B8-C1A9B07B2002Q41762429-81231F1F-D7A3-4EE9-B0C7-DBBFB88E674CQ42428507-AF1C5174-3BEF-4052-A335-C109B44F1AFCQ44172753-256B6DBB-954F-48DF-96B1-98ABC038E05BQ44540699-C37DF800-8B67-487B-9EEC-64BBC43C9844Q44685077-1A27DC3D-B859-4804-A1A0-D39B4099C3ECQ44765723-A25DE2DF-4EBF-4D4F-9D62-1811FA03B9A1Q45043102-9095FEB1-1BBA-45BA-8AF2-621E763A885AQ45334831-143A106C-09D9-47BA-9AC7-D08918ED8194Q47102964-419BCA28-5C0B-40F5-B164-7D3380079BD9Q47766044-900C1757-D578-462D-8611-7387753B98FB
P2860
Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Renal function-based contrast ...... aneous coronary interventions.
@en
Renal function-based contrast ...... aneous coronary interventions.
@nl
type
label
Renal function-based contrast ...... aneous coronary interventions.
@en
Renal function-based contrast ...... aneous coronary interventions.
@nl
prefLabel
Renal function-based contrast ...... aneous coronary interventions.
@en
Renal function-based contrast ...... aneous coronary interventions.
@nl
P2093
P1476
Renal function-based contrast ...... aneous coronary interventions.
@en
P2093
Adam Greenbaum
BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) Registry
David Share
Dean E Smith
Mauro Moscucci
Simon R Dixon
Thomas Lalonde
P304
P356
10.1016/J.JACC.2011.05.023
P407
P577
2011-08-01T00:00:00Z